{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:16:12Z","timestamp":1790864172244,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T00:00:00Z","timestamp":1242345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s11906-009-0038-1","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T12:56:11Z","timestamp":1242305771000},"page":"217-223","source":"Crossref","is-referenced-by-count":33,"title":["Differential diagnosis of primary aldosteronism subtypes"],"prefix":"10.1007","volume":"11","author":[{"given":"Paolo","family":"Mulatero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bertello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Verhovez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giraudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Mengozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Limerutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Avenatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Tizzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Veglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,15]]},"reference":[{"key":"38_CR1","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"J.W. Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, et al.: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008, 93:3266\u20133281.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tem.2005.02.007","volume":"16","author":"P. Mulatero","year":"2005","unstructured":"Mulatero P, Dluhy RG, Giacchetti G, et al.: Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 2005, 16:114\u2013119.","journal-title":"Trends Endocrinol Metab"},{"key":"38_CR3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P. Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, et al.: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005, 45:1243\u20131248.","journal-title":"J Am Coll Cardiol"},{"key":"38_CR4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/187152506775268776","volume":"4","author":"P. Mulatero","year":"2006","unstructured":"Mulatero P, Milan A, Williams TA, Veglio F: Mineralocorticoid receptor blockade in the protection of target organ damage. Cardiovasc Hematol Agents Med Chem 2006, 4:75\u201391.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2006-0078","volume":"91","author":"P. Mulatero","year":"2006","unstructured":"Mulatero P, Milan A, Fallo F, et al.: Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab 2006, 91:2618\u20132623.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","volume":"91","author":"F. Fallo","year":"2006","unstructured":"Fallo F, Veglio F, Bertello C, et al.: Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 2006, 91:454\u2013459.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"G.P. Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Desideri G, et al.: Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 2006, 48:232\u2013238.","journal-title":"Hypertension"},{"key":"38_CR8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P. Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, et al.: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004, 89:1045\u20131050.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jcem-41-5-809","volume":"41","author":"S. Todesco","year":"1975","unstructured":"Todesco S, Terribile V, Borsatti A, Mantero F: Primary aldosteronism due to a malignant ovarian tumor. J Clin Endocrinol Metab 1975, 41:809\u2013819.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR10","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1056\/NEJM200105173442017","volume":"344","author":"P. Mulatero","year":"2001","unstructured":"Mulatero P, Rabbia F, Veglio F: Paraneoplastic hyperaldosteronism associated with non-Hodgkin\u2019s lymphoma. N Engl J Med 2001, 344:1558\u20131559.","journal-title":"N Engl J Med"},{"key":"38_CR11","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/jc.2007-2055","volume":"93","author":"P. Mulatero","year":"2008","unstructured":"Mulatero P, Bertello C, Rossato D, et al.: Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab 2008, 93:1366\u20131371.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR12","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","volume":"21","author":"M. Stowasser","year":"2003","unstructured":"Stowasser M, Gordon RD, Gunasekera TG, et al.: High rate of detection of primary aldosteronism, including surgically treatable forms, after \u201cnon-selective\u201d screening of hypertensive patients. J Hypertens 2003, 21:2149\u20132157.","journal-title":"J Hypertens"},{"key":"38_CR13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","volume":"66","author":"W.F. Young","year":"2007","unstructured":"Young WF: Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol 2007, 66:607\u2013618.","journal-title":"Clin Endocrinol"},{"key":"38_CR14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","volume":"2","author":"M. Stowasser","year":"2001","unstructured":"Stowasser M, Gordon RD, Rutherford JC, et al.: Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2001, 2:156\u2013169.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"38_CR15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"W.F. Young","year":"2004","unstructured":"Young WF, Stanson AW, Thompson GB, et al.: Role for adrenal venous sampling in primary aldosteronism. Surgery 2004, 136:1227\u20131235.","journal-title":"Surgery"},{"key":"38_CR16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03349761","volume":"18","author":"R.D. Gordon","year":"1995","unstructured":"Gordon RD: Primary aldosteronism. J Endocrinol Invest 1995, 18:495\u2013511.","journal-title":"J Endocrinol Invest"},{"key":"38_CR17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/jcem-36-2-401","volume":"36","author":"A. Ganguly","year":"1973","unstructured":"Ganguly A, Dowdy AJ, Luetscher JA, Melada GA: Anomalous postural response of plasma aldosterone concentration in patients with aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 1973, 36:401\u2013404.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0889-8529(18)30425-0","volume":"17","author":"W.F. Young Jr","year":"1988","unstructured":"Young WF Jr, Klee GG: Primary aldosteronism. Diagnostic evaluation. Endocrinol Metab Clin North Am 1988, 17:367\u2013395.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"38_CR19","first-page":"S103","volume":"5","author":"R.D. Gordon","year":"1987","unstructured":"Gordon RD, Gomez-Sanchez CE, Hamlet SM, et al.: Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J Hypertens Suppl 1987, 5:S103\u2013S106.","journal-title":"J Hypertens Suppl"},{"key":"38_CR20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/jcem-49-1-87","volume":"49","author":"E.G. Biglieri","year":"1979","unstructured":"Biglieri EG, Schambelan M: The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. J Clin Endocrinol Metab 1979, 49:87\u201391.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jcem.86.3.7287","volume":"86","author":"G.P. Rossi","year":"2001","unstructured":"Rossi GP, Sacchetto A, Chiesura-Corona M, et al.: Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001, 86:1083\u20131090.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR22","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","volume":"144","author":"W.F. Young Jr","year":"2003","unstructured":"Young WF Jr: Minireview\u2014primary aldosteronism: changing concepts in diagnosis and treatment. Endocrinology 2003, 144:2208\u20132213.","journal-title":"Endocrinology"},{"key":"38_CR23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/HJH.0b013e3282f9e66a","volume":"26","author":"G.P. Rossi","year":"2008","unstructured":"Rossi GP, Pitter G, Bernante P, et al.: Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens 2008, 26:989\u2013997.","journal-title":"J Hypertens"},{"key":"38_CR24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.surg.2006.07.026","volume":"140","author":"A. Harvey","year":"2006","unstructured":"Harvey A, Kline G, Pasieka JL: Adrenal venous sampling in primary hyperaldosteronism: comparison of radiographic with biochemical success and the clinical decision-making with \u201cless than ideal\u201d testing. Surgery 2006, 140:847\u2013855.","journal-title":"Surgery"},{"key":"38_CR25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1148\/radiology.198.2.8596821","volume":"198","author":"J.L. Doppman","year":"1996","unstructured":"Doppman JL, Gill JR Jr: Hyperaldosteronism: sampling the adrenal veins. Radiology 1996, 198:309\u2013312.","journal-title":"Radiology"},{"key":"38_CR26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/archsurg.141.5.497","volume":"141","author":"F.E. Nwariaku","year":"2006","unstructured":"Nwariaku FE, Miller BS, Auchus R, et al.: Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg 2006, 141:498\u2013502.","journal-title":"Arch Surg"},{"key":"38_CR27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11906-007-0017-3","volume":"9","author":"G.P. Rossi","year":"2007","unstructured":"Rossi GP: New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism. Curr Hypertens Rep 2007, 9:90\u201397.","journal-title":"Curr Hypertens Rep"},{"key":"38_CR28","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1373\/clinchem.2007.092080","volume":"53","author":"G. Mengozzi","year":"2007","unstructured":"Mengozzi G, Rossato D, Bertello C, et al.: Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin Chem 2007, 53:1968\u20131971.","journal-title":"Clin Chem"},{"key":"38_CR29","first-page":"460","volume":"16","author":"R.T. Kloos","year":"1995","unstructured":"Kloos RT, Gross MD, Francis IR, et al.: Incidentally discovered adrenal masses. Endocr Rev 1995, 16:460\u2013484.","journal-title":"Endocr Rev"},{"key":"38_CR30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00004872-200404000-00001","volume":"22","author":"P. Mulatero","year":"2004","unstructured":"Mulatero P, Morello F, Veglio F: Genetics of primary aldosteronism. J Hypertens 2004, 22:663\u2013670.","journal-title":"J Hypertens"},{"key":"38_CR31","first-page":"1109","volume":"95","author":"D.J.A. Sutherland","year":"1966","unstructured":"Sutherland DJA, Ruse JC, Laidlaw JC: Hypertension increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. J Can Med Assoc 1966, 95:1109\u20131119.","journal-title":"J Can Med Assoc"},{"key":"38_CR32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1043-2760(03)00112-7","volume":"14","author":"M. Stowasser","year":"2003","unstructured":"Stowasser M, Gordon RD: Primary aldosteronism: from genesis to genetics. Trends Endocrinol Metab 2003, 14:310\u2013317.","journal-title":"Trends Endocrinol Metab"},{"key":"38_CR33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"R.P. Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, et al.: A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992, 355:262\u2013265.","journal-title":"Nature"},{"key":"38_CR34","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1210\/jcem.87.7.8647","volume":"87","author":"P. Mulatero","year":"2002","unstructured":"Mulatero P, di Cella SM, Williams TA, et al.: Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree. J Clin Endocrinol Metab 2002, 87:3187\u20133191.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.jhh.1001636","volume":"18","author":"F. Fallo","year":"2004","unstructured":"Fallo F, Pilon C, Williams TA, et al.: Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism. J Hum Hypertens 2004, 18:47\u201351.","journal-title":"J Hum Hypertens"},{"key":"38_CR36","first-page":"1507","volume":"82","author":"W. Litchfield","year":"1997","unstructured":"Litchfield W, Coolidge C, Silva P, et al.: Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 1997, 82:1507\u20131510.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","volume":"31","author":"W.R. Litchfield","year":"1998","unstructured":"Litchfield WR, Anderson BF, Weiss RJ, et al.: Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 1998, 31:445\u2013450.","journal-title":"Hypertension"},{"key":"38_CR38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/01.HYP.35.2.668","volume":"35","author":"J.A. Wyckoff","year":"2000","unstructured":"Wyckoff JA, Seely EW, Hurwitz S, et al.: Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension 2000, 35:668\u2013672.","journal-title":"Hypertension"},{"key":"38_CR39","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1210\/jcem.83.7.4946","volume":"83","author":"P. Mulatero","year":"1998","unstructured":"Mulatero P, Veglio F, Pilon C, et al.: Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab 1998, 83:2573\u20132575.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR40","first-page":"1863","volume":"85","author":"C.E. Fardella","year":"2000","unstructured":"Fardella CE, Mosso L, G\u00f2mez-Sanchez C, et al.: Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000, 85:1863\u20131867.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR41","first-page":"3996","volume":"83","author":"P. Mulatero","year":"1998","unstructured":"Mulatero P, Curnow KM, Aupetit-Faisant B, et al.: Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab 1998, 83:3996\u20134001.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/bbrc.1995.1225","volume":"207","author":"J.R. Jonsson","year":"1995","unstructured":"Jonsson JR, Klemm SA, Tunny TJ, et al.: A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Comm 1995, 207:565\u2013571.","journal-title":"Biochem Biophys Res Comm"},{"key":"38_CR43","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jcem.85.9.6834","volume":"85","author":"M. Stowasser","year":"2000","unstructured":"Stowasser M, Bachmann AW, Huggard PJ, et al.: Treatment of familial hyperaldosteronism type I: only partial suppression of hybrid gene required to correct hypertension. J Clin Endocrinol Metab 2000, 85:3313\u20133318.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","volume":"18","author":"R.D. Gordon","year":"1991","unstructured":"Gordon RD, Stowasser M, Tunny TJ, et al.: Clinical and pathological diversity of primary aldosteronism including a new familial variety. Clin Exper Pharmacol Physiol 1991, 18:283\u2013286.","journal-title":"Clin Exper Pharmacol Physiol"},{"key":"38_CR45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","volume":"37","author":"A.R. Lafferty","year":"2000","unstructured":"Lafferty AR, Torpy D, Stowasser M, et al.: A novel genetic locus for low-renin hypertension: familial hyperaldosteronism type-II maps to chromosome 7 (7p22). J Med Genet 2000, 37:831\u2013835.","journal-title":"J Med Genet"},{"key":"38_CR46","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/HJH.0b013e3283028352","volume":"28","author":"N. Sukor","year":"2008","unstructured":"Sukor N, Mulatero P, Gordon RD, et al.: Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J Hypertens 2008, 28:1577\u20131582.","journal-title":"J Hypertens"},{"key":"38_CR47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","volume":"351","author":"R.S. Vasan","year":"2004","unstructured":"Vasan RS, Evans JC, Larson MG, et al.: Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004, 351:33\u201341.","journal-title":"N Engl J Med"},{"key":"38_CR48","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","volume":"49","author":"C. Newton-Cheh","year":"2007","unstructured":"Newton-Cheh C, Guo CY, Gona P, et al.: Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 2007, 49:846\u2013856.","journal-title":"Hypertension"},{"key":"38_CR49","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","volume":"93","author":"D.S. Geller","year":"2008","unstructured":"Geller DS, Zhang JJ, Wisgerhof MV, et al.: A novel form of human Mendelian hypertension featuring non-glucocorticoid remediable aldosteronism. J Clin Endocrinol Metab 2008, 93:3117\u20133123.","journal-title":"J Clin Endocrinol Metab"},{"key":"38_CR50","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1210\/jc.2008-1241","volume":"93","author":"P. Mulatero","year":"2008","unstructured":"Mulatero P: A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J Clin Endocrinol Metab 2008, 93:2972\u20132974.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-009-0038-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-009-0038-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-009-0038-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:14:23Z","timestamp":1559434463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-009-0038-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,15]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s11906-009-0038-1","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,15]]}}}